Analysts predict that GNC Holdings Inc (NYSE:GNC) will post $0.24 earnings per share for the current quarter, according to Zacks. Zero analysts have provided estimates for GNC’s earnings, with the lowest EPS estimate coming in at $0.09 and the highest estimate coming in at $0.39. GNC posted earnings per share of $0.41 during the same quarter last year, which indicates a negative year-over-year growth rate of 41.5%. The firm is expected to announce its next earnings results on Thursday, July 26th.
According to Zacks, analysts expect that GNC will report full year earnings of $0.87 per share for the current financial year, with EPS estimates ranging from $0.41 to $1.23. For the next fiscal year, analysts expect that the firm will report earnings of $0.76 per share, with EPS estimates ranging from $0.31 to $1.20. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research analysts that cover GNC.
GNC (NYSE:GNC) last issued its earnings results on Thursday, April 26th. The specialty retailer reported $0.24 EPS for the quarter, topping the Zacks’ consensus estimate of $0.22 by $0.02. The business had revenue of $607.50 million for the quarter, compared to analyst estimates of $573.32 million. GNC had a negative net margin of 6.89% and a negative return on equity of 84.23%. The company’s quarterly revenue was down 7.2% compared to the same quarter last year. During the same period last year, the company posted $0.37 earnings per share.
A number of equities analysts have recently commented on the stock. Barclays reduced their target price on shares of GNC from $4.50 to $3.50 and set an “underweight” rating on the stock in a research report on Friday, April 27th. Zacks Investment Research lowered shares of GNC from a “hold” rating to a “sell” rating in a research report on Friday, February 16th. Finally, JPMorgan Chase dropped their price objective on shares of GNC from $7.00 to $6.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 14th. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the stock. GNC currently has a consensus rating of “Hold” and a consensus price target of $6.25.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. SG Americas Securities LLC boosted its stake in shares of GNC by 311.0% during the fourth quarter. SG Americas Securities LLC now owns 348,703 shares of the specialty retailer’s stock valued at $1,287,000 after purchasing an additional 263,865 shares in the last quarter. Spark Investment Management LLC bought a new position in shares of GNC during the fourth quarter valued at approximately $2,883,000. Arrowstreet Capital Limited Partnership bought a new position in shares of GNC during the fourth quarter valued at approximately $440,000. MANA Advisors LLC bought a new position in shares of GNC during the fourth quarter valued at approximately $1,155,000. Finally, Elephas Investment Management Ltd bought a new position in shares of GNC during the fourth quarter valued at approximately $19,310,000. Hedge funds and other institutional investors own 56.81% of the company’s stock.
Shares of GNC opened at $3.40 on Monday, Marketbeat reports. The company has a market cap of $284.46 million, a PE ratio of 2.52 and a beta of 0.85. GNC has a one year low of $3.08 and a one year high of $10.95. The company has a debt-to-equity ratio of -5.93, a quick ratio of 0.49 and a current ratio of 1.50.
GNC Company Profile
GNC Holdings, Inc, together with its subsidiaries, operates as a specialty retailer of health, wellness, and performance products. It operates through three segments: U.S. and Canada, International, and Manufacturing/Wholesale. Its products include protein, performance supplements, weight management supplements, vitamins, herbs and greens, wellness supplements, health and beauty, food and drink, and other general merchandise.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for GNC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GNC and related companies with MarketBeat.com's FREE daily email newsletter.